Tracking movement and speech in frontotemporal degeneration
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This study uses a wearable sensor and a phone app to track how frontotemporal degeneration affects movement and speaking. If you have FTD, this could help doctors detect changes earlier and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 or older.
- You need a diagnosis of frontotemporal degeneration (a brain disorder that can affect personality, behavior, speech, and movement).
- You and a caregiver (a partner, family member, or friend) must be willing to help with the study.
- You need to read and speak English fluently.
- You should not have more than 5 falls per month.
- You should not have other serious medical or mental conditions that would make study activities hard.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests wearable sensors to remotely monitor people with frontotemporal dementia. It aims to help doctors track symptoms from home, which may reduce the need for clinic visits.
This study looks at testing (including brain scans) to figure out what type of frontotemporal dementia or related language/speech condition a person has. It may help by making diagnoses more accurate, which can guide better care.
This study follows people with frontotemporal dementia (FTLD) and related conditions, and collects health and (for some people) body fluid information, to understand how these illnesses change over time. It may help researchers track disease signs and find better ways to measure progression.
This study collects health information from people with neurodegenerative diseases, some family members, and healthy controls to help researchers better understand these conditions. It may help future diagnosis and research, and participation may include noninvasive checks and other procedures depending on your situation.
This study tests a non-invasive brain stimulation technique called tACS (transcranial alternating current stimulation) in people with frontotemporal dementia. The goal is to see if it can improve symptoms like behavior and language problems.
This research study tracks how brain damage progresses in rare neurodegenerative diseases like frontotemporal dementia, primary progressive aphasia, PSP, CBS, and ALS. Researchers use brain imaging and tests to understand how these diseases spread in the brain, which could help develop better treatments.
Hear when a new Frontotemporal Lobar Degeneration (FTLD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.